Study reveals best ways to adjust ulcerative colitis treatment for better living

NCT ID NCT05271773

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at 234 adults with ulcerative colitis whose gut lining had healed (Mayo 0 or 1). Researchers tracked how increasing, decreasing, or switching treatments affected patients' quality of life over 6 and 12 months. They also measured inflammation markers like fecal calprotectin. The goal was to find the best treatment approach for maintaining well-being.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IBD (INFLAMMATORY BOWEL DISEASE) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospital Marqués de Valdecilla

    Santander, Cantabria, 39008, Spain

  • Hospital Universitari Parc Taulí

    Sabadell, Catalonia, 08208, Spain

  • Hospital Universitario La Paz

    Madrid, 28046, Spain

  • Hospital Universitario La Princesa

    Madrid, 28006, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, 28034, Spain

  • Hospital Universitario de Canarias

    San Cristóbal de La Laguna, Santa Cruz De Tenerife, 38018, Spain

  • Hospital Universitario de Cáceres

    Cáceres, Extremadura, 10004, Spain

  • Hospital Universitario de Santiago de Compostela

    Santiago de Compostela, Galicia, 15706, Spain

  • Hospital Universitario. Miguel Servet

    Zaragoza, 50009, Spain

  • Hospital de Santa Bárbara de Puertollano

    Puertollano, Ciudad Real, 13500, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.